Pharmaceutical Executive
WEBThe latest news for pharma industry insiders. Magnolia Medical Announces New Platform to Reduce Misdiagnosis of Sepsis. By Mike Hollan. July 1st 2024. CDC’s Advisory Committee Unanimously Recommends Vaxelis to Prevent Invasive Hemophilus Influenzae Type B in American Indian and Alaska Native Infants. By Don Tracy, Associate Editor.
2023 Pharm Exec Top 50 Companies
WEBJun 10, 2023 · Movers and shakers. As mentioned, Pfizer and AbbVie captured the top two spots again in the Pharma 50—the latter, notably, expected to maintain its solid momentum, even with Humira’s patent expiration this year, thanks to reinforcements Skyrizi for psoriasis (up 75.7% in sales in 2022 to $5.2 billion) and JAK inhibitor Rinvoq (with seven approvals so far, including rheumatoid arthritis and ...
2022 Pharm Exec Top 50 Companies
WEBJun 9, 2022 · Quarterly sales for its heart drug Entresto rose 42% to $1.1 billion. The rest of the Pharma 50 top 10, with each one rising or dropping a spot or two, include BMS at No. 6; Merck at No, 7, Sanofi at No. 8; AZ, as mentioned, taking the ninth spot, and GSK at No. 10. Each posted Rx sales increases year-over-year.
2021 Pharm Exec Top 50 Companies
WEBJun 9, 2021 · Manning the last two positions in the Pharma 50 top 10 are once again GlaxoSmithKline and Takeda. GSK, still planning to split the organization into two next year, recently announced plans to sell its complete stake in respiratory drug partner Innoviva (a royalty management company) for about $392 million.
Pharmaceutical Executive - PharmExec
WEBMaster the Science of Success through aspirational coverage for executive-level decisions, leadership, management, strategy and commercialization professionals.
Pharm Exec's Top 50 Companies 2020
WEBJul 9, 2020 · Together, BMS and Celgene spent an estimated $9.4 billion in R&D last year, ranking second in this metric, with Johnson & Johnson and Merck manning third and fourth, respectively. Earlier this year, Brand Finance, the independent branded business valuation consultancy, named J&J its 2020 most valuable pharma company, due to …
Pharm Exec 50: The World's Top 50 Pharmaceutical Companies
WEBMay 1, 2006 · Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.
Pharmaceutical Executive's 2022 Emerging Pharma Leaders
WEBMay 11, 2022 · Click on the links below to read the profiles of Pharm Exec's 2022 Emerging Pharma Leaders.. Naveen Bazaj, Head of Corporate Development, Alector. Gardner Gendron, Chief/US Head of Commercial, NS Pharma. Aida Habtezion, MD, Senior VP, Chief Medical Officer, and Head of Worldwide Medical and Safety, Pfizer. Matthew J. Hawryluk, PhD, Executive VP, Chief Business Officer and Cambridge Site Head ...
Pharma 2022 (10/11/22 - 10/13) - PharmExec
WEBPharma 2022 (10/11/22 - 10/13) October 11, 2022. Event. We’ve entered a new era. One where being risk averse is the riskiest strategy, long-established operating models have been torn up and reimagined, and where investment into digital innovation – both culturally and financially – has ignited.
Our View on 2022: Pharm Exec’s Annual Industry Outlook
WEBJan 11, 2022 · Our View on 2022: Pharm Exec’s Annual Industry Outlook. January 11, 2022. Publication. Article. Pharmaceutical Executive Pharmaceutical Executive-01-01-2022. Volume 42. Issue 1. Follow the links below to read about each trend: Logistics - …
Skip to content